September 5, 2023 | Berlin
Eckert & Ziegler Eurotope GmbH (Eckert & Ziegler) and SCINTOMICS Molecular, Applied Theranostics Technologies GmbH (SCI-att) have successfully started a long-term collaboration to produce disposable consumables for SCI-att’s proprietary GRP radiosynthesis platform.
Within the agreement, Eckert & Ziegler has started GMP-compliant production of the first batches of synthesis cassettes at its in-house clean room facility in Berlin. The contract cassette manufacturing is performed in a validated process that was audited by SCI-att at the beginning of this year.
“With this agreement, Eckert & Ziegler is opening up to external partners and making its expertise and capacities in cassette production available as a service from now on”, explained Dr. Sven-Peter Heyn, general manager of Eckert & Ziegler Eurotope GmbH. “We have manufactured hundreds of thousands of radiosynthesis cassettes for various applications using our Modular-Lab technology over the past decade. Now we are pleased that SCI-att also relies on our experience for these sensitive consumables used in the patient dose preparation of radiopharmaceuticals.”
“SCI-att radiosynthesis systems are used by numerous international clinics in the daily routine production of radiotracers”, stated Andrea Maugg, CEO of SCINTOMICS Molecular, ATT GmbH. “The quality and reliability of the cassettes is a fundamental prerequisite for safe patient care. In Eckert & Ziegler we have found a production partner that has already proven that they can provide both.”
Eckert & Ziegler’s clean rooms and manufacturing processes have already been successfully audited by various of its customers in the past. Transfer of custom-designed cassettes to a GMP-compliant routine manufacturing process follows the One-Stop-Shop idea and is an integral part of Eckert & Ziegler’s contract development and manufacturing services (CDMO) for radiopharmaceuticals, medical devices and beyond.
About Eckert & Ziegler Eurotope GmbH
Eurotope GmbH belongs to the Eckert & Ziegler group and represents the Lab Devices business unit of the Medical Segment. The company develops, manufactures, and sells systems and accessories for radionuclide labeling and quality control of radiopharmaceuticals. The products are used in research and routine manufacturing of patient doses for cancer diagnosis and therapy in hospitals as well as in industrial manufacturing processes for radioactively labeled compounds and drugs.
As part of the Medical Segment, Eurotope GmbH contributes to provide complete solutions for Eckert & Ziegler´s worldwide customers in the nuclear medicine and pharma industry. The comprehensive product and service portfolio ranges from customized hot cell solutions and in-cell equipment over radionuclides to contract development and GMP-manufacturing services for radiopharmaceuticals through all stages from early clinical to commercial supply.
About SCINTOMICS Molecular, att GmbH
SCINTOMICS Molecular, Applied Theranostics Technologies (SCI-att), established in 2018, is a prominent and fast-growing player in the radiopharmaceutical industry. With a strategic focus on ensuring a consistent supply and comprehensive support for proprietary and innovative tracer technology and non-IP protected precursors, such as PSMA I&T and next-generation PSMA inhibitors like siPSMA-14 and SiFAlinTATE, SCI-att stands at the forefront of cutting-edge theranostics solutions.
As a subsidiary of Scintomics GmbH, SCI-att took over the prestigious GRP Module Series in 2020, further enhancing our capabilities and product offerings. We are dedicated to expanding our portfolio and providing our customers with an unparalleled portfolio of products and services. At SCI-att, we pride ourselves on delivering top-notch quality and exceptional customer support.